glp 1 receptor agonists and dpp 4 inhibitors DPP4 vs GLP-1 | June 2021 | Clinical Corner GLP-1 receptor agonists or DPP-4
Description
These adherence challenges have a direct impact on treatment outcomes, particularly for managing PCOS
Huang X, Wu M, Lin J, Mou L, Zhang Y, Jiang J
Peptides (1990) 11(3):46772
Before we start looking ahead, we want to take stock of where 2024 left the AOM market
Interestingly, many people with fatty liver disease actually see an improvement in these markers as they lose weight on GLP-1 therapy
